Physician profile
Sherwin Arman
NPI 1821135138
$469.83
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.46 · 2021: $63.44 · 2022: $222 · 2023: $55.02 · 2024: $31.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $111.89 | 2021-2022 | |
| Amgen INC. | $87.48 | 2019-2023 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $62.16 | 2019-2023 | Ajovy |
| Abbvie INC. | $49.37 | 2022 | |
| Impel Pharmaceuticals INC. | $36.47 | 2022 | |
| Depuy Synthes Sales INC. | $34.95 | 2019 | |
| Lilly USA, LLC | $31.04 | 2024 | Emgality |
| Biolase, INC. | $30.08 | 2022 | |
| Lundbeck LLC | $26.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherwin Arman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.